Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong
· Delayed Price · Currency is HKD 3.430
+0.040 (1.18%)
At close: Mar 10, 2026
Zhaoke Ophthalmology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 35.36 | 69.32 | 18.75 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | -38.20% | 269.73% | - | - | - | - | Upgrade
|
| Cost of Revenue | 17.93 | 17.53 | 4.5 | - | - | - | Upgrade
|
| Gross Profit | 17.42 | 51.8 | 14.25 | - | - | - | Upgrade
|
| Selling, General & Admin | 128.56 | 134.28 | 136.29 | 116.06 | 178.82 | 36.54 | Upgrade
|
| Research & Development | 226.96 | 203.7 | 333.05 | 296.43 | 220.06 | 81.78 | Upgrade
|
| Other Operating Expenses | 12.94 | 12.94 | -1.26 | -0.15 | -0.01 | -1.37 | Upgrade
|
| Operating Expenses | 368.45 | 350.92 | 468.09 | 412.34 | 398.87 | 116.96 | Upgrade
|
| Operating Income | -351.03 | -299.12 | -453.84 | -412.34 | -398.87 | -116.96 | Upgrade
|
| Interest Expense | -9.03 | -9.5 | -7.92 | -3.14 | -1.95 | -1.66 | Upgrade
|
| Interest & Investment Income | 75.23 | 75.23 | 77.4 | 30.42 | 5.04 | 2.58 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.71 | -4.71 | -3.65 | -29.73 | 13.41 | -5.49 | Upgrade
|
| Other Non Operating Income (Expenses) | 15.71 | - | - | - | -1,763 | -669.98 | Upgrade
|
| EBT Excluding Unusual Items | -273.83 | -238.11 | -388.01 | -414.8 | -2,146 | -791.49 | Upgrade
|
| Asset Writedown | -10.81 | -10.81 | - | - | - | - | Upgrade
|
| Other Unusual Items | 6.32 | 11.42 | 3.52 | 7.48 | 16.09 | 64.51 | Upgrade
|
| Pretax Income | -278.31 | -237.49 | -384.49 | -407.32 | -2,130 | -726.98 | Upgrade
|
| Income Tax Expense | - | - | 0.55 | - | - | - | Upgrade
|
| Net Income | -278.31 | -237.49 | -385.04 | -407.32 | -2,130 | -726.98 | Upgrade
|
| Net Income to Common | -278.31 | -237.49 | -385.04 | -407.32 | -2,130 | -726.98 | Upgrade
|
| Shares Outstanding (Basic) | 546 | 546 | 544 | 542 | 412 | 151 | Upgrade
|
| Shares Outstanding (Diluted) | 546 | 546 | 544 | 542 | 412 | 151 | Upgrade
|
| Shares Change (YoY) | 0.20% | 0.41% | 0.32% | 31.47% | 173.12% | -5.63% | Upgrade
|
| EPS (Basic) | -0.51 | -0.43 | -0.71 | -0.75 | -5.16 | -4.81 | Upgrade
|
| EPS (Diluted) | -0.51 | -0.43 | -0.71 | -0.75 | -5.16 | -4.81 | Upgrade
|
| Free Cash Flow | -253 | -263.82 | -360.13 | -409.7 | -310.67 | -169.79 | Upgrade
|
| Free Cash Flow Per Share | -0.46 | -0.48 | -0.66 | -0.76 | -0.75 | -1.12 | Upgrade
|
| Gross Margin | 49.28% | 74.72% | 75.98% | - | - | - | Upgrade
|
| Operating Margin | -992.78% | -431.49% | -2420.47% | - | - | - | Upgrade
|
| Profit Margin | -787.13% | -342.58% | -2053.54% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -715.53% | -380.56% | -1920.70% | - | - | - | Upgrade
|
| EBITDA | -314.86 | -263.22 | -420.16 | -384.55 | -377.53 | -100.7 | Upgrade
|
| D&A For EBITDA | 36.17 | 35.91 | 33.68 | 27.78 | 21.34 | 16.25 | Upgrade
|
| EBIT | -351.03 | -299.12 | -453.84 | -412.34 | -398.87 | -116.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.